MYR Pharma Completes Phase 2b Study of Myrcludex B

XableCath's Peripheral Arterial Catheters Gets US Patent

Avillion Inks Drug Development Deal with Pearl Therapeutics

Biocon & Mylan's Biosimilar Trastuzumab Gets ANVISA Nod

Takeda to Acquire TiGenix for EUR 520 Million

Mallinckrodt Seeks US FDA Approval for Stannsoporfin

US FDA Approves to Market Lupin's Generic Dovonex Scalp Solution

US FDA Accepts NDA for Acacia Pharma's Baremsis

Datavant, Verge Genomics Ink Strategic Drug Development Deal

US FDA Okays Marketing of Zydus' Clomipramine HCl Capsules

US FDA Accepts GW Pharma's NDA Filing for Epidiolex

BioMatrix Partners with Genentech

Kernal Biologics & QurAlis Win Amgen Golden Ticket at LabCentral

Rimidi, Eli Lilly Ink Deal

Medicure Acquires Exclusive License to Sell & Market Branded Cardiovascular Drug in US

DKSH India Wins Ashland "Best Channel Partner" Award for Rest of Asia Region

Pfizer's Psoriatic arthritis Drugs Get US FDA Nod

Gilead Sciences to Appoint John C Martin as New Chairman

Cipla Gets US FDA Nod for Generic Pulmicort Respules

Chugai to Sell Production Right of 13 Medication to Taiyo Pharma

AstraZeneca Receives US FDA Approval for Faslodex

DCGI Approves Heteros Generic FDC Drug 'Darunavir + Ritonavir'

Novartis Join Hands with ASCP & ACS to Fight Cancer in Sub-Saharan Africa

Sawai Forms Strategic Alliance with Sumitomo Corporation

EC Approves Sandoz's Rixathon

Merrimack Completes Enrollment in Phase 2 CARRIE Study of MM-141

Axovant Sciences Receives US FDA Fast Track Status for Nelotanserin

US FDA Marketing Nod for Zydus Eletriptan Hydrobromide Tablets

RASRx Gets US FDA Orphan Drug Status for RASRx1902

US FDA approves Darzalex in Combo with Pomalidomide & Dexamethasone

PharmaMar to Commercialize PM1183 with Trade Name of Zepsyre

ThromboGenics Appoints Thomas Clay as Chairman

US FDA Approves Lannett Generic Xyzal Oral Solution

Dr Reddy's Generic Doxil Gets US FDA Nod

Boston Scientific Announces Positive Results from REPRISE III Trial

Saudi FDA Approves Sobiís Orfadin Capsules

Novartis Initiative to Tackle Hypertension and its Root Causes

Bayer's Copanlisib Receives Priority Review Status from US FDA

US FDA Approves Monitored Therapeutics' GoSpiro Home Spirometer

Hitgen & Pfizer to Build and Screen Novel DNA Encoded Libraries

US FDA Gives Breakthrough Therapy Designation to Novartis' CTL019

Abeome Inks Research Deal with CDC

CASI Pharma Pauses Patients Enrolment in ENMD-2076 Phase 2 Study

Novotech Signs MoU with SouthKorea's AMC

Protalix Announce Positive Results Alidornase Alfa Phase II Trial

India's Biosimilar Norms Equal with Global Requirements

Glenmark's Generic Pradaxa Capsules Gets US FDA Tentative Approval

Omnicell Buys Mississippi-based nPharmics

Verona Signs Collaboration to Develop Dry Powder and Metered Dose Inhaler Formulations for COPD

Rigel Pharma Submits NDA to US FDA for Fostamatinib

Calypso, EA Pharma to Develop & Market CALY-001

Allergan, Novartis to Conduct Clinical Trial to Treat NASH

Japan Vaccine Co Seeks Japanese Approval for Shingrix

Flow Chemistry for API Commercial Manufacturing

Pfizer's Xeljanz Gets Chinese FDA Nod

Diplomat Pharmacy to Dispense Kisqali for Metastatic Breast Cancer

Biogen Appoints Anirvan Ghosh as sr VP, RED

AstraZeneca Partners with Circassia Pharma

VolitionRx Forms Wholly-owned US Subsidiary

Glenmark Receives US FDA Tentative Approval for Fingolimod Capsules

Zydus Cadila Acquires Sentynl Therapeutics

Lilly to Buy US-based CoLucid Pharma

Caris Life, Lustgarten Foundation Collaborate

Takeda, Ovid Therapeutics Form Global Collaboration for TAK-935

Voxtur Bio Introduces Cardiac Testing Range

leon-nanodrugs, Bionpharma to Develop Dermatological Product